Profil
Liong Ho Chua is currently the President-Greater China Region at Clover Biopharmaceuticals Ltd. Prior to this, he was the Chief Strategy Officer & Executive President at AIM Vaccine Co., Ltd. from 2019 to 2022.
Mr. Chua received his undergraduate degree from the National University of Singapore.
Postes actifs de Liong Ho Chua
| Sociétés | Poste | Début |
|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Corporate Officer/Principal | 27/04/2022 |
Anciens postes connus de Liong Ho Chua
| Sociétés | Poste | Fin |
|---|---|---|
| AIM VACCINE CO., LTD. | Corporate Officer/Principal | 01/03/2022 |
Formation de Liong Ho Chua
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
National University of Singapore
National University of Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AIM Vaccine Co., Ltd.
AIM Vaccine Co., Ltd. BiotechnologyHealth Technology Engages in biotechnology development operation | Health Technology |
Clover Biopharmaceuticals Ltd.
Clover Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
















